CoChat

Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes

Open access
Flusberg, Deborah A., Roux, Jérémie, Spencer, Sabrina L., Sorger, Peter K. · 2013 · Molecular Biology of the Cell
Cited by 96

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

When clonal populations of human cells are exposed to apoptosis-inducing agents, some cells die and others survive. This fractional killing arises not from mutation but from preexisting, stochastic differences in the levels and activities of proteins regulating apoptosis. Here we examine the properties of cells that survive treatment with agonists of two distinct death receptors, tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and anti-FasR antibodies. We find that “survivor” cells are highly resistant to a second ligand dose applied 1 d later. Resistance is reversible, resetting after several days of culture in the absence of death ligand. “Reset” cells appear identical to drug-naive cells with respect to death ligand sensitivity and gene expression profiles. TRAIL survivors are cross-resistant to activators of FasR and vice versa and exhibit an NF-κB–dependent inflammatory phenotype. Remarkably, reversible resistance is induced in the absence of cell death when caspase inhibitors are present and can be sustained for 1 wk or more, also without cell death, by periodic ligand exposure. Thus stochastic differences in cell state can have sustained consequences for sen­sitivity to prodeath ligands and acquisition of proinflammatory phenotypes. The important role played by periodicity in TRAIL exposure for induction of opposing apoptosis and survival mechanisms has implications for the design of optimal therapeutic agents and protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1091/mbc.e12-10-0737

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 103

  1. Albeck JG, 2008, Mol Cell, 30, 11, 10.1016/j.molcel.2008.02.012 · DOI · Paper page
  2. Aldridge BB, 2011, Mol Syst Biol, 7, 553, 10.1038/msb.2011.85 · DOI · Paper page
  3. Ashkenazi A, 2008, Cytokine Growth Factor Rev, 19, 325, 10.1016/j.cytogfr.2008.04.001 · DOI · Paper page
  4. Ashkenazi A, 1999, Curr Opin Cell Biol, 11, 255, 10.1016/S0955-0674(99)80034-9 · DOI · Paper page
  5. Ashkenazi A, 2008, J Clin Invest, 118, 1979, 10.1172/JCI34359 · DOI · Paper page
  6. Austin CD, 2006, Proc Natl Acad Sci USA, 103, 10283, 10.1073/pnas.0604044103 · DOI · Paper page
  7. Banno T, 2004, J Biol Chem, 279, 32633, 10.1074/jbc.M400642200 · DOI · Paper page
  8. Banno T, 2005, J Biol Chem, 280, 18973, 10.1074/jbc.M411758200 · DOI · Paper page
  9. Bargmann CI, 1986, Cell, 45, 649, 10.1016/0092-8674(86)90779-8 · DOI · Paper page
  10. Barnhart BC, 2004, EMBO J, 23, 3175, 10.1038/sj.emboj.7600325 · DOI · Paper page
  11. Bhola PD, 2009, J Cell Sci, 122, 4296, 10.1242/jcs.055590 · DOI
  12. Boehm JS, 2007, Cell, 129, 1065, 10.1016/j.cell.2007.03.052 · DOI · Paper page
  13. Breitschopf K, 2000, J Biol Chem, 275, 21648, 10.1074/jbc.M001083200 · DOI · Paper page
  14. Brooks AD, 2010, Mol Cancer Res, 8, 729, 10.1158/1541-7786.MCR-10-0022 · DOI
  15. Chang DW, 2002, EMBO J, 21, 3704, 10.1093/emboj/cdf356 · DOI · Paper page
  16. Chaudhary PM, 1997, Immunity, 7, 821, 10.1016/S1074-7613(00)80400-8 · DOI · Paper page
  17. Chen L, 2010, Nature, 465, 492, 10.1038/nature09075 · DOI · Paper page
  18. Cohen AA, 2008, Science, 322, 1511, 10.1126/science.1160165 · DOI · Paper page
  19. Debnath J, 2003, Methods, 30, 256, 10.1016/S1046-2023(03)00032-X · DOI · Paper page
  20. Deng Y, 2002, Genes Dev, 16, 33, 10.1101/gad.949602 · DOI · Paper page
  21. Deveraux QL, 1997, Nature, 388, 300, 10.1038/40901 · DOI · Paper page
  22. Diessenbacher P, 2008, J Invest Dermatol, 128, 1134, 10.1038/sj.jid.5701141 · DOI
  23. Edgar R, 2002, Nucleic Acids Res, 30, 207, 10.1093/nar/30.1.207 · DOI · Paper page
  24. Ehrhardt H, 2003, Oncogene, 22, 3842, 10.1038/sj.onc.1206520 · DOI · Paper page
  25. Eldar A, 2010, Nature, 467, 167, 10.1038/nature09326 · DOI · Paper page
  26. Eskes R, 2000, Mol Cell Biol, 20, 929, 10.1128/MCB.20.3.929-935.2000 · DOI · Paper page
  27. Falschlehner C, 2007, Int J Biochem Cell Biol, 39, 1462, 10.1016/j.biocel.2007.02.007 · DOI · Paper page
  28. Feig C, 2007, EMBO J, 26, 221, 10.1038/sj.emboj.7601460 · DOI · Paper page
  29. Flusberg DA, 2013, Phys Biol, 10, 035002, 10.1088/1478-3975/10/3/035002 · DOI
  30. Frese-Schaper M, 2010, FEBS Lett, 584, 2867, 10.1016/j.febslet.2010.04.072 · doi:10.1016/j.febslet.2010.04.072
  31. Ganten TM, 2005, Hepatology, 42, 588, 10.1002/hep.20807 · DOI · Paper page
  32. Gaudet S, 2012, PLoS Comput Biol, 8, e1002482, 10.1371/journal.pcbi.1002482 · DOI · Paper page
  33. Gonzalvez F, 2010, Oncogene, 29, 4752, 10.1038/onc.2010.221 · DOI · Paper page
  34. Guicciardi ME, 2009, FASEB J, 23, 1625, 10.1096/fj.08-111005 · DOI · Paper page
  35. Gupta A, 2010, Proc Natl Acad Sci USA, 107, 14333, 10.1073/pnas.1000248107 · DOI · Paper page
  36. Gupta PB, 2011, Cell, 146, 633, 10.1016/j.cell.2011.07.026 · DOI · Paper page
  37. Harper N, 2003, J Biol Chem, 278, 44338, 10.1074/jbc.M307376200 · DOI
  38. Harper N, 2008, Methods Enzymol, 446, 293, 10.1016/S0076-6879(08)01618-2 · DOI
  39. Hellwig CT, 2008, J Biol Chem, 283, 21676, 10.1074/jbc.M802889200 · DOI · Paper page
  40. Hellwig CT, 2012, Mol Cancer Therapeut, 11, 3, 10.1158/1535-7163.MCT-11-0434 · DOI
  41. Hughes MA, 2009, Mol Cell, 35, 265, 10.1016/j.molcel.2009.06.012 · DOI · Paper page
  42. Ishimura N, 2006, Am J Physiol Gastrointest Liver Physiol, 290, G129, 10.1152/ajpgi.00242.2005 · DOI · Paper page
  43. Jang JH, 2008, Gut, 57, 492, 10.1136/gut.2007.137703 · DOI
  44. Jansen BJ, 2003, J Invest Dermatol, 121, 1433, 10.1046/j.1523-1747.2003.12636.x · DOI
  45. Jeremias I, 1998, Eur Cytokine Netw, 9, 687
  46. Johnstone RW, 2008, Nat Rev Cancer, 8, 782, 10.1038/nrc2465 · DOI · Paper page
  47. Kataoka T, 2004, Mol Cell Biol, 24, 2627, 10.1128/MCB.24.7.2627-2636.2004 · DOI · Paper page
  48. Kim JH, 2008, Biochem Biophys Res Commun, 377, 195, 10.1016/j.bbrc.2008.09.095 · DOI
  49. Kischkel FC, 1995, EMBO J, 14, 5579, 10.1002/j.1460-2075.1995.tb00245.x · DOI · Paper page
  50. Kohlhaas SL, 2007, J Biol Chem, 282, 12831, 10.1074/jbc.M700438200 · DOI
  51. Lane D, 2006, Mol Cancer Therapeut, 5, 509, 10.1158/1535-7163.MCT-05-0362 · DOI
  52. Lavrik IN, 2007, J Biol Chem, 282, 13664, 10.1074/jbc.M700434200 · DOI · Paper page
  53. Le Roy C, 2005, Nat Rev Mol Cell Biol, 6, 112, 10.1038/nrm1571 · DOI · Paper page
  54. Lee MW, 2005, Cancer Invest, 23, 586, 10.1080/07357900500283036 · DOI
  55. Li JH, 2003, J Immunol, 171, 1526, 10.4049/jimmunol.171.3.1526 · DOI · Paper page
  56. Li S, 2002, J Biol Chem, 277, 26912, 10.1074/jbc.M200726200 · DOI · Paper page
  57. Li Z, 2011, J Biol Chem, 286, 21164, 10.1074/jbc.M110.207571 · doi:10.1074/jbc.m110.207571
  58. Lin Y, 2000, Mol Cell Biol, 20, 6638, 10.1128/MCB.20.18.6638-6645.2000 · DOI · Paper page
  59. Luo JL, 2005, J Clin Invest, 115, 2625, 10.1172/JCI26322 · DOI · Paper page
  60. Malhi H, 2006, Oncogene, 25, 7333, 10.1038/sj.onc.1209765 · DOI
  61. Martin DA, 1998, J Biol Chem, 273, 4345, 10.1074/jbc.273.8.4345 · DOI · Paper page
  62. Mazurek N, 2011, Cell Death Differ, 19, 523, 10.1038/cdd.2011.123 · DOI
  63. Menke C, 2011, Cancer Res, 71, 1883, 10.1158/0008-5472.CAN-10-2252 · doi:10.1158/0008-5472.can-10-2252
  64. Muppidi JR, 2004, Immunity, 21, 461, 10.1016/j.immuni.2004.10.001 · DOI · Paper page
  65. Muranen T, 2012, Cancer Cell, 21, 227, 10.1016/j.ccr.2011.12.024 · DOI · Paper page
  66. Neumann L, 2010, Mol Syst Biol, 6, 352, 10.1038/msb.2010.6 · DOI · Paper page
  67. Opel D, 2011, Clin Cancer Res, 17, 3233, 10.1158/1078-0432.CCR-10-2530 · DOI · Paper page
  68. Rehm M, 2002, J Biol Chem, 277, 24506, 10.1074/jbc.M110789200 · DOI · Paper page
  69. Rehm M, 2006, EMBO J, 25, 4338, 10.1038/sj.emboj.7601295 · DOI · Paper page
  70. Rehm M, 2009, Cell Death Differ, 16, 613, 10.1038/cdd.2008.187 · DOI
  71. Roesch A, 2010, Cell, 141, 583, 10.1016/j.cell.2010.04.020 · DOI · Paper page
  72. Rossin A, 2009, Biochem J, 419, 185, 10.1042/BJ20081212 · DOI · Paper page
  73. Sabnis GJ, 2008, Cancer Res, 68, 4518, 10.1158/0008-5472.CAN-07-5999 · DOI · Paper page
  74. Santner SJ, 2001, Breast Cancer Res Treat, 65, 101, 10.1023/A:1006461422273 · DOI · Paper page
  75. Sayers TJ, 2006, Cancer Immunol Immunother, 55, 76, 10.1007/s00262-005-0676-3 · DOI
  76. Scaffidi C, 1999, J Biol Chem, 274, 1541, 10.1074/jbc.274.3.1541 · DOI · Paper page
  77. Sharp DA, 2005, J Biol Chem, 280, 19401, 10.1074/jbc.M413962200 · DOI · Paper page
  78. Siegel RM, 1999, J Allergy Clin Immunol, 103, 729, 10.1016/S0091-6749(99)70412-4 · DOI
  79. Sigal A, 2006, Nature, 444, 643, 10.1038/nature05316 · DOI · Paper page
  80. Singh DK, 2010, Mol Syst Biol, 6, 369, 10.1038/msb.2010.22 · DOI · Paper page
  81. Son JK, 2010, Cell Death Differ, 17, 1288, 10.1038/cdd.2010.9 · DOI
  82. Song JH, 2007, Cancer Res, 67, 6946, 10.1158/0008-5472.CAN-06-3896 · DOI · Paper page
  83. Song JJ, 2007, J Biol Chem, 282, 319, 10.1074/jbc.M608065200 · DOI
  84. Song JJ, 2009, Cell Signal, 22, 377, 10.1016/j.cellsig.2009.10.007 · DOI · Paper page
  85. Song JJ, 2010, Cell Signal, 22, 553, 10.1016/j.cellsig.2009.11.012 · doi:10.1016/j.cellsig.2009.11.012
  86. Spencer SL, 2009, Nature, 459, 428, 10.1038/nature08012 · DOI · Paper page
  87. Sun BK, 2010, Int J Oncol, 38, 249
  88. Sun BK, 2010, Oncol Rep, 25, 537
  89. Sun XM, 2002, J Biol Chem, 277, 11345, 10.1074/jbc.M109893200 · DOI · Paper page
  90. Takeda K, 2002, J Exp Med, 195, 161, 10.1084/jem.20011171 · DOI · Paper page
  91. Tang W, 2009, FEBS J, 276, 581, 10.1111/j.1742-4658.2008.06809.x · DOI
  92. Tang Z, 2006, Mol Cell Biol, 26, 5588, 10.1128/MCB.00199-06 · DOI
  93. Trauth BC, 1989, Science, 245, 301, 10.1126/science.2787530 · DOI · Paper page
  94. Trauzold A, 2006, Oncogene, 25, 7434, 10.1038/sj.onc.1209719 · DOI · Paper page
  95. Varfolomeev E, 2005, J Biol Chem, 280, 40599, 10.1074/jbc.M509560200 · DOI · Paper page
  96. Wagner KW, 2007, Nat Med, 13, 1070, 10.1038/nm1627 · DOI · Paper page
  97. Wajant H, 2003, Cytokine Growth Factor Rev, 14, 53, 10.1016/S1359-6101(02)00072-2 · DOI · Paper page
  98. Wilson NS, 2009, Nat Immunol, 10, 348, 10.1038/ni.1714 · DOI · Paper page
  99. Yan J, 2013, Cell, 152, 304, 10.1016/j.cell.2012.12.021 · DOI
  100. Yoshida T, 2009, Mol Cancer Res, 7, 1835, 10.1158/1541-7786.MCR-09-0244 · DOI
  101. Zauli G, 2005, J Cell Physiol, 202, 900, 10.1002/jcp.20202 · DOI
  102. Zhang L, 2005, Cancer Gene Ther, 12, 228, 10.1038/sj.cgt.7700792 · DOI · Paper page
  103. Zhang Y, 2009, Cancer Biol Ther, 8, 917, 10.4161/cbt.8.10.8141 · DOI

Cited by

See all 96

Metadata

Authors
Flusberg, D. A., Roux, J., Spencer, S. L., & Sorger, P. K.
Venue
Molecular Biology of the Cell
Published
2013-07-15
Volume
24
Issue
14
Pages
2186-2200
ISSN
  • 1059-1524 (ISSN-L)
  • 1939-4586
OpenAlex
W2132672330
Cited by
96
References
14
FWCI
4.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. https://app.cochat.ai/papers/10.1091/mbc.e12-10-0737
The paper
Flusberg, D. A., Roux, J., Spencer, S. L., & Sorger, P. K. (2013). Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e12-10-0737

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.